Cipla Ltd (CIPL.BO)
16 Mar 2018
Indian shares rose nearly 1 percent on Thursday, snapping seven sessions of fall, as market heavyweights such as Infosys Ltd and Housing Development Finance Corp helped the indexes end their longest spell of losses since September.
Feb 8 Indian shares rose more than 1 percent on Thursday after seven consecutive sessions of declines, as market heavyweights such as Infosys recovered and as drug maker Cipla gained on solid earnings.
** Shares of Cipla Ltd surge as much as 6.85 pct to 608.2 rupees, in their biggest intraday pct gain since Nov 2016
Cipla Ltd, India's fourth-largest drugmaker by revenue, said third-quarter net profit rose 7 percent on strong domestic sales, but fell short of analysts' estimates.
Feb 7 Cipla Ltd, India's fourth-largest drugmaker by revenue, said third-quarter net profit rose 7 percent on strong domestic sales, but fell short of analysts' estimates.
* SAYS KEY PERFORMANCE METRICS LOOK HEALTHY AND ARE INLINE WITH CO'S INTERNAL TARGETS Source text - http://bit.ly/2BhN3M6 Further company coverage:
Feb 7 Cipla Ltd, India's fourth-largest drugmaker by revenue, posted an about 7 percent rise in third-quarter net profit on Wednesday, but missed analysts' estimates.
* DEC QUARTER CONSOL NET PROFIT 4.01 BILLION RUPEES VERSUS PROFIT OF 3.75 BILLION RUPEES LAST YEAR
* GETS ANDA FOR TENOFOVIR DISOPROXIL FUMARATE TABLETS FROM U.S. FDA Source text - http://bit.ly/2DW6lbS Further company coverage:
* KIADIS PHARMA PROPOSES FORMER CIPLA CEO SUBHANU SAXENA AS NEW SUPERVISORY BOARD MEMBER